ADA: Insulin Does Not Hike Cancer Risk (CME/CE)

CHICAGO (MedPage Today) -- The use of insulin glargine (Lantus) is not associated with an increased risk of any cancer in people with diabetes or prediabetes, according to a substudy of the prospective ORIGIN trial.
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news